Business Context and Reporting Period
Company: Beyond Meat, Inc. (BYND)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025
Business Overview: Beyond Meat is a leading plant-based meat company offering beef, pork, and poultry platforms. The company operates in a single segment and faces persistent declines in category demand, macroeconomic headwinds, and intense competition. In 2025, the company executed a "Global Operations Review," ceasing operations in China, rationalizing SKUs, and implementing significant workforce reductions to reduce costs and improve margins.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Net Revenues | $275.5 million | $326.5 million | (15.6%) |
| Gross Profit | $7.6 million | $41.7 million | (81.7%) |
| Gross Margin | 2.8% | 12.8% | N/A |
| Loss from Operations | $(333.6) million | $(156.1) million | (113.7%) |
| Net Income (Loss) | $219.0 million | $(160.3) million | N/A |
| Operating Cash Flow | $(144.9) million | $(98.8) million | N/A |
| Cash & Equivalents | $203.9 million | $131.9 million | N/A |
| Total Debt (Net) | $415.7 million | $1,141.5 million | (63.6%) |
Note: The 2025 Net Income of $219.0 million is primarily driven by a non-cash gain on debt restructuring of $548.7 million resulting from an Exchange Offer. Without this gain, the company reported a significant operating loss.
Material Changes vs. Prior Period
- Revenue Decline: Net revenues decreased 15.6% due to a 15.9% decrease in volume sold, driven by weak category demand in U.S. retail and foodservice channels and loss of distribution internationally.
- Debt Restructuring: The company completed an Exchange Offer in October 2025, exchanging 97.44% of its 2027 Notes for new 2030 Notes and common stock. This resulted in a $548.7 million gain on debt restructuring and a significant reduction in total debt principal.
- Asset Impairments & Write-downs:
- Recorded a $51.3 million impairment loss on long-lived assets in Q3 2025 due to lower performance and sustained stock price decline.
- Recorded $49.0 million in loss on write-down of assets held for sale in Q4 2025, including $45.6 million related to non-core assets and $3.4 million related to China operations.
- China Exit: Operational activities in China ceased in 2025, resulting in $6.4 million in accelerated depreciation and additional write-downs.
- Legal Accruals: Recorded a $38.9 million litigation-related accrual in SG&A expenses following a jury verdict in a trademark infringement case (Sonate Corp).
Guidance, Outlook, and Risks
- Outlook: Management expects to continue operating at a loss for the foreseeable future. The company is focused on cost reduction, inventory management, and gross margin expansion. They believe existing cash balances are sufficient to fund operations for the next twelve months.
- Liquidity Constraints: The company is unable to access its "At-The-Market" (ATM) equity program because it failed to file its 10-K on time, losing eligibility for Form S-3. It has drawn the full $100 million under its Delayed Draw Term Loan facility.
- Key Risks:
- Delisting Risk: Received a Nasdaq deficiency notice for failing to maintain the $1.00 minimum bid price. The company has 180 days to regain compliance or risk delisting.
- Internal Controls: Management identified two material weaknesses in internal controls: (1) accounting for non-routine/complex transactions and (2) inventory valuation/data integrity. The auditor issued an adverse opinion on internal controls.
- Regulatory: Ongoing legal challenges regarding the use of "meat" terminology in the EU and other jurisdictions.
- Debt Covenants: The company was temporarily in default on its Loan and Security Agreement due to late filing of audited statements but expects to remedy this upon filing.
Investor Verification Checklist
- Verify Debt Structure: Confirm the terms of the new 2030 Notes (7% PIK Toggle) and the $100M Delayed Draw Term Loan (12% PIK interest) to understand future cash burn and dilution risks.
- Assess Liquidity Runway: Given the suspension of the ATM program and negative operating cash flow, verify if the $203.9M cash balance is sufficient to cover operations and debt service without further dilutive financing.
- Monitor Nasdaq Compliance: Track the stock price to determine if a reverse stock split or other action is required to avoid delisting by August 31, 2026.
- Review Litigation Exposure: Monitor the status of the Sonate Corp trademark case (accrued $38.9M) and the Interbev dispute in France regarding product naming.
- Validate Inventory Valuation: Given the material weakness in inventory controls and the $2.4M incremental provision for excess inventory in Q4, scrutinize future inventory write-downs.